Read articles from Asia

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.

September 23, 2026 by vapingpost.com

Bloomberg-funded tobacco control is facing renewed scrutiny at the same time the latest GSTHR report shows a global shift towards safer nicotine use. That contrast matters: billions can be spent resisting products that consumers are already using to move away from cigarettes. Public health should be accountable not only for its intentions, but for whether its influence helps reduce smoking or keeps harm reduction politically inconvenient.

September 22, 2026 by planetofthevapes.co.uk

Malaysia’s vape ban debate should raise concern for anyone focused on outcomes rather than appearances. Removing legal access to lower-risk products can push consumers towards illicit supply, reduce oversight and leave adult smokers with cigarettes as the more stable option. Youth protection deserves strong enforcement, but broad bans often weaken the very safeguards they claim to create. A better approach would regulate vaping responsibly while keeping the route away from combustion open.

September 16, 2026 by manilatimes.net

The Asia-Pacific Declaration puts access at the centre of tobacco harm reduction. Safer nicotine products cannot reduce smoking-related harm while they remain unavailable, unaffordable or pushed outside legal markets. The region needs regulation that reflects real consumer behaviour, local smoking burdens and the difference between combustible and non-combustible products. Public health progress depends on giving adults practical routes away from cigarettes, not limiting the conversation to abstinence alone.

September 08, 2026 by gfn.tv

The science on heated tobacco products sits in the space between cigarette harm and smoke-free innovation. These products still involve tobacco, but they do not burn it in the same way cigarettes do, making exposure data and real-world switching patterns essential. The key is not to overstate certainty or ignore risk, but to understand where they sit on the nicotine risk spectrum. Better regulation starts with that comparison.

September 07, 2026 by tobaccoinsider.com

Asia’s nicotine regulation is moving in many directions at once: tighter cigarette controls, new rules for vapes, disputes over pouches and continued pressure from illicit trade. That patchwork matters because adult smokers do not experience policy as a regional trend; they experience it as access, price, risk information and legal certainty. Regulation that ignores product differences can protect cigarettes by default. A stronger approach would recognise local realities while keeping the goal clear: less smoking, less combustion and fewer preventable harms.

August 31, 2026 by gfn.tv

Nasvay is often discussed as a category, but its production shows why details matter. Traditional smokeless tobacco products can vary widely in ingredients, preparation, hygiene and risk, making regulation far more complex than a simple ban-or-allow debate. Understanding how these products are made helps public health distinguish between cultural practice, consumer demand and preventable harm. Better policy starts with looking closely at what people actually use, not only at what institutions prefer to classify.

August 25, 2026 by prlog.org

Viet Nam faces a choice between controlling nicotine pouches through regulation or pushing them into a market with no accountability. Prohibition may look decisive, but it rarely removes demand; it usually removes product standards, age controls and consumer protection. A regulated approach would give authorities more oversight while allowing adult smokers access to lower-risk alternatives. Harm reduction is stronger when governments shape the market rather than pretend it can be made to disappear.

August 25, 2026 by prlog.org

Viet Nam faces a choice between controlling nicotine pouches through regulation or pushing them into a market with no accountability. Prohibition may look decisive, but it rarely removes demand; it usually removes product standards, age controls and consumer protection. A regulated approach would give authorities more oversight while allowing adult smokers access to lower-risk alternatives. Harm reduction is stronger when governments shape the market rather than pretend it can be made to disappear.